Colour sensor breath test can detect lung cancer

Feb 26, 2007

A breath test can successfully pick up lung cancer with "moderate accuracy" even in the early stages, reveals research published ahead of print in Thorax.

It could revolutionise the way cancer is detected and potentially save lives, say the authors.

The test comprises a chemical colour sensor, which detects tiny changes in the unique chemical signature of the breath of people with lung cancer.

Metabolic changes in lung cancer cells cause changes in the production and processing of volatile organic compounds, which are then breathed out

The researchers used the colour sensor to test the breath of 122 people with different types of respiratory disease, and 21 healthy people.

Included in the group with respiratory illness were 49 people with small cell lung cancer at various stages of development.

The research team used the sensor results from 70% of the study participants to develop a predictive model, the accuracy of which was then tested on the remaining 30%.

The results showed that the test was able to accurately predict the presence of cancer in just under three out of four of those with lung cancer.

The results were not affected by age, gender, or stage of disease.

Other approaches to breath testing have been used, say the authors. This includes gas chromatography and mass spectrometry, which requires a great deal of expertise to use and is very expensive.

As cancer is often silent in its early stages and symptoms are often not specific, it is often difficult to pick up the disease at a stage when it could be treated effectively, say the authors.

Diagnosis is often therefore only made when the disease is advanced.

"Ultimately, this line of investigation could lead to an inexpensive, non-invasive screening or diagnostic test for lung cancer," they conclude.

Source: BMJ Specialty Journals

Explore further: Eight ways to prevent breast cancer​​​​​​

add to favorites email to friend print save as pdf

Related Stories

Team uses nanoparticles to enhance chemotherapy

Jul 07, 2014

(Phys.org) —University of Georgia researchers have developed a new formulation of cisplatin, a common chemotherapy drug, that significantly increases the drug's ability to target and destroy cancerous cells.

Possible benefit from online genetic testing for lung cancer

Jun 30, 2009

As scientists continue to decode the human genome and the information becomes publicly available, private companies that offer online genetic testing are multiplying. Scientists at the National Institutes of Health were concerned ...

Recommended for you

Study pinpoints microRNA tied to colon cancer tumor growth

13 hours ago

Researchers at the University of Minnesota have identified microRNAs that may cause colon polyps from turning cancerous. The finding could help physicians provide more specialized, and earlier, treatment before colon cancer ...

Obesity tied to higher cancer risk for CRC survivors

14 hours ago

(HealthDay)—Colorectal cancer (CRC) patients who are overweight or obese when diagnosed appear to face a slightly higher risk for developing a second weight-related cancer, according to research published ...

User comments : 0